US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist

15.630
-0.230-1.45%

Trading May 23 11:53 ET

402.05MMarket Cap-121162P/E (TTM)

Contineum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Contineum Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

Revenue(YoY)

0.00

0.00%

EPS(YoY)

-0.31

-7.53%

Analyst Rating

Strong Buy

Apr 30, 2024

Contineum Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q3	-- / 0.000	--
--	2024/Q2	-- / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q3-- / 0.000--

--2024/Q2-- / 0.000--

--2024/Q10.000 / 0.000--

Contineum Therapeutics Earnings Reports

Contineum Therapeutics | 10-Q: Quarterly report

May 16 17:04 ET

Analysis

Analyst Rating

Updated: Apr 30, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Overall